Showing results (41-50 of 103) with videos related to
Sort By:
Pageof 11
The Journal of Pharmacology and Experimental Therapeutics|August 20, 2009
Thioflavin S (NSC71948) interferes with Bcl-2-associated athanogene (BAG-1)-mediated protein-protein interactionsAdam Sharp, Simon J Crabb, Peter W M Johnson, et al.Chemotherapy|August 22, 2012
A phase I clinical trial of irinotecan and carboplatin in patients with extensive stage small cell lung cancerSimon J Crabb, Jennifer Bradbury, Luke Nolan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2025
CD27 Agonist Antibodies Mediate Clinical Responses through Intratumoral Stimulation in B-cell Malignancies: Multicenter RiVa TrialLara E Buermann, Louise Stanton, Matthew J J Rose-Zerilli, et al.Journal of the National Cancer Institute|September 19, 2002
The effects of malignant transformation on susceptibility of human urothelial cells to CD40-mediated apoptosisUrszula Bugajska, Nikolaos T Georgopoulos, Jennifer Southgate, et al.Journal of Immunology (Baltimore, Md. : 1950)|May 27, 2014
Differential impact of CD27 and 4-1BB costimulation on effector and memory CD8 T cell generation following peptide immunizationJane E Willoughby, Jonathan P Kerr, Anne Rogel, et al.Cancer Cell|December 5, 2017
Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid RecruitmentAnna H Turaj, Khiyam Hussain, Kerry L Cox, et al.Cancer Immunology, Immunotherapy : CII|April 2, 2013
FcγRΙΙB controls the potency of agonistic anti-TNFR mAbsAnn L White, H T Claude Chan, Ruth R French, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2025
PET-Based Risk Stratification in Primary Mediastinal B-Cell Lymphoma: A Comparative Analysis of Different Segmentation Methods in the IELSG37 Trial Patient CohortLuca Ceriani, Lisa Milan, Maria Cristina Pirosa, et al.Cancer Immunology, Immunotherapy : CII|April 23, 2013
Antibody-peptide-MHC fusion conjugates target non-cognate T cells to kill tumour cellsBen C King, Angela D Hamblin, Philip M Savage, et al.Blood|October 24, 2002
Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid raftsMark S Cragg, Suzanne M Morgan, H T Claude Chan, et al.Pageof 11